Cutaneous T-Cell Lymphomas: A Review of New Discoveries and Treatments

Predictors of complete responses with denileukin diftitox in cutaneous T-cell lymphoma

(2011) Francine Foss et al.   AMERICAN JOURNAL OF HEMATOLOGY

The Stanford University Experience With Conventional-Dose, Total Skin Electron-Beam Therapy in the Treatment of Generalized Patch or Plaque (T2) and Tumor (T3) Mycosis Fungoides

(2011) Daniel Navi et al.   ARCHIVES OF DERMATOLOGY

Multicenter Phase II Trial of Temozolomide in Mycosis Fungoides/Sezary Syndrome: Correlation with O6-Methylguanine-DNA Methyltransferase and Mismatch Repair Proteins

(2011) C. Querfeld et al.   CLINICAL CANCER RESEARCH

Inhibition of Glycogen Synthase Kinase-3 Increases the Cytotoxicity of Enzastaurin

(2011) Mark A. Rovedo et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Antibody-based therapeutics to watch in 2011

(2011) Janice M. Reichert   mAbs

Phototherapy of mycosis fungoides

(2011) Franz Trautinger   PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE

Increased Programmed Death-1 Expression on CD4+ T Cells in Cutaneous T-Cell Lymphoma

(2010) Sara Samimi et al.   ARCHIVES OF DERMATOLOGY

Reduction of Fas/CD95 Promoter Methylation, Upregulation of Fas Protein, and Enhancement of Sensitivity to Apoptosis in Cutaneous T-Cell Lymphoma

(2010) Jianqiang Wu et al.   ARCHIVES OF DERMATOLOGY

Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma

(2010) M. R. Kamstrup et al.   BLOOD

Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors

(2010) J. J. Campbell et al.   BLOOD

Transcriptional Profiles Predict Disease Outcome in Patients with Cutaneous T-Cell Lymphoma

(2010) I. V. Litvinov et al.   CLINICAL CANCER RESEARCH

Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma

(2010) Frederick Lansigan et al.   DRUGS

Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma

(2010) M. B. Wozniak et al.   HAEMATOLOGICA

Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

(2010) Rafael F. Duarte et al.   JOURNAL OF CLINICAL ONCOLOGY

Total Skin Electron Beam and Non-Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation in Advanced Mycosis Fungoides and Sézary Syndrome

(2010) Madeleine Duvic et al.   JOURNAL OF CLINICAL ONCOLOGY

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

(2010) Sean J. Whittaker et al.   JOURNAL OF CLINICAL ONCOLOGY

Genome-Wide Analysis of Cutaneous T-Cell Lymphomas Identifies Three Clinically Relevant Classes

(2010) Elodie Laharanne et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)

(2010) Elise A. Olsen et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center

(2010) Christiane Querfeld et al.   LEUKEMIA & LYMPHOMA

CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma

(2010) Elodie Laharanne et al.   MODERN PATHOLOGY

A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome

(2009) Peggy A. Wu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases

(2009) P. T. Bradford et al.   BLOOD

Bexarotene therapy for mycosis fungoides and Sézary syndrome

(2009) R.A. Abbott et al.   BRITISH JOURNAL OF DERMATOLOGY

Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma

(2009) E. Bisaccia et al.   BRITISH JOURNAL OF DERMATOLOGY

Lack of T-Cell Receptor-Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death

(2009) C.-D. Klemke et al.   CANCER RESEARCH

Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

(2009) Chelsea C. Pinnix et al.   CANCER RESEARCH

Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked Activity in T-Cell Malignancies

(2009) Owen A. O'Connor et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

(2009) Richard L. Piekarz et al.   JOURNAL OF CLINICAL ONCOLOGY

Downregulation of Fas Gene Expression in Sézary Syndrome Is Associated with Promoter Hypermethylation

(2009) Christine L. Jones et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells

(2008) E. Rosati et al.   BLOOD

Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation

(2008) S. O. Arulogun et al.   BLOOD

Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome

(2008) R. van Doorn et al.   BLOOD

Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma

(2008) R F Duarte et al.   BONE MARROW TRANSPLANTATION

Psoralen plus ultraviolet A ± interferon-α treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-κB and T-cell receptor pathways

(2008) M.B. Wozniak et al.   BRITISH JOURNAL OF DERMATOLOGY

Effects on erythropoiesis of alemtuzumab-containing reduced intensity and standard conditioning regimens

(2008) Aleksandar Mijovic et al.   BRITISH JOURNAL OF HAEMATOLOGY

Novel and Highly Recurrent Chromosomal Alterations in Sezary Syndrome

(2008) M. H. Vermeer et al.   CANCER RESEARCH

Array-based comparative genomic hybridization in early-stage mycosis fungoides: Recurrent deletion of tumor suppressor genesBCL7A, SMAC/DIABLO, andRHOF

(2008) Angelo Carbone et al.   GENES CHROMOSOMES & CANCER

Low FAS/CD95 Expression by CTCL Correlates with Reduced Sensitivity to Apoptosis that Can Be Restored by FAS Upregulation

(2008) Jianqiang Wu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome

(2008) Camille E. Introcaso et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY